ProSellus

JANUARY 25, 2019

ProSellus, one of the fastest growing healthcare tech start-ups, recently released a significant upgrade to their Marketing & Sales Acceleration Platform. The post 2018 Healthcare Procedure & Diagnosis Data powered by ProSellus appeared first on ProSellus.

Healthcare 52

Healthcare Healthcare Sales Marketing 52

Healthcare Success

MAY 9, 2022

We know that today’s healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . History of QR Codes in Healthcare Marketing .

Leads 112

Leads Patients Healthcare Provider Healthcare 112

Healthcare Success

MAY 9, 2022

We know that today's healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . History of QR Codes in Healthcare Marketing .

Leads 52

Leads Patients Healthcare Provider Healthcare 52

Clarivate

FEBRUARY 28, 2023

Through a comparative analysis of published LHON prevalence data and real-world evidence, this article describes a study using multiple Clarivate TM data sets to better understand disease pathology and current drug utilization for this condition. real world data set covers 90% of the insured population in all U.S.

Prescription 98

Prescription Patients Pharmacology Healthcare 98

pharmaphorum

JANUARY 4, 2023

The proposed EHDS Regulation 1 ( Proposal ), introduced in May 2022 by the European Commission (EC), aims to reform the “situation of fragmentation” that depicts the existing approach to health data access across Europe 2 through the establishment of a centralised data system. Background. Rights for individuals.

Pharmaceutical 86

Pharmaceutical Electronics Healthcare Healthcare 86

Pharmaceutical Technology

NOVEMBER 30, 2022

Mounjaro is the first weight loss drug to show efficacy rates comparable to surgical procedures like sleeve gastrectomies. Several other treatments, like Novo Nordisk’s CagriSema (semaglutide + cagrilintide), are expected to follow after showing encouraging Phase II data. The UK and US are both undergoing an obesity crisis.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Mounjaro is the first weight loss drug to show efficacy rates comparable to surgical procedures like sleeve gastrectomies. Several other treatments, like Novo Nordisk’s CagriSema (semaglutide + cagrilintide), are expected to follow after showing encouraging Phase II data. The UK and US are both undergoing an obesity crisis.

Medical 98

Medical Manufacturing Insurance Side effects 98